Zhejiang Sunflower Great Health Co., Ltd. (SHE:300111)
3.340
-0.060 (-1.76%)
Jun 2, 2026, 3:04 PM CST
SHE:300111 Revenue
Zhejiang Sunflower Great Health had revenue of 54.56M CNY in the quarter ending March 31, 2026, a decrease of -24.46%. This brings the company's revenue in the last twelve months to 253.87M, down -20.40% year-over-year. In the year 2025, Zhejiang Sunflower Great Health had annual revenue of 271.53M, down -17.81%.
Revenue (ttm)
253.87M
Revenue Growth
-20.40%
P/S Ratio
16.94
Revenue / Employee
837.84K
Employees
303
Market Cap
4.30B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 271.53M | -58.83M | -17.81% |
| Dec 31, 2024 | 330.37M | -8.05M | -2.38% |
| Dec 31, 2023 | 338.42M | 2.56M | 0.76% |
| Jan 1, 2023 | 335.86M | 38.57M | 12.97% |
| Jan 1, 2022 | 297.29M | 10.33M | 3.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zhejiang Starry Pharmaceutical | 2.47B |
| Yabao Pharmaceutical Group | 2.20B |
| Hunan Fangsheng Pharmaceutical | 1.79B |
| Henan Taloph Pharmaceutical Stock Co.,Ltd | 1.78B |
| Bide Pharmatech | 1.35B |
| Teyi Pharmaceutical Group Co.,Ltd | 839.27M |
| Hubei Biocause Heilen Pharmaceutical | 459.02M |
| Beijing Science Sun Pharmaceutical | 402.62M |